Foamix (FOMX) Reports Q1 Loss of $0.39/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. ANET
8. SPY
9. XYZ
10. CVS

Go back to Foamix (FOMX) Reports Q1 Loss of $0.39/Share

Foamix Reports First Quarter 2017 Financial Results and Provides Business Update

May 9, 2017 4:06 PM EDT

REHOVOT, Israel, May 9, 2017 /PRNewswire/ -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX) ("Foamix Pharmaceuticals" or the "Company"), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address unmet needs in dermatology, announced today financial results for the three months ended March 31, 2017.

Clinical, business and corporate developments for the three months ended March 31, 2017 and to date:

On March 27, 2017, we provided the top-line data from our two Phase 3 clinical trials (Trial 04 and 05) for FMX101 in the... More